Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Briscoe

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Cancer Research|November 12, 2009
Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cellsDipak Datta, Alan G Contreras, Aninda Basu, et al.
Current Opinion in Organ Transplantation|November 30, 2016
The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/toleranceJohannes Wedel, Hironao Nakayama, Nora M Kochupurakkal, et al.
Pediatric Nephrology (Berlin, Germany)|April 24, 2015
Translational implications of endothelial cell dysfunction in association with chronic allograft rejectionSarah Bruneau, Johannes Wedel, Fadi Fakhouri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma productionAninda Basu, Andre Hoerning, Dipak Datta, et al.
Biochemical and Biophysical Research Communications|September 23, 2019
Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activationCraig B Woda, Sarah Bruneau, Anne Linde Mak, et al.
Carcinogenesis|December 29, 2021
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantationAkash Sabarwal, Johannes Wedel, Kaifeng Liu, et al.
The American Journal of Pathology|January 27, 2006
Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injurySei-ichiro Tsuchihashi, Bibo Ke, Fady Kaldas, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 2, 2015
Microfluidic mazes to characterize T-cell exploration patterns following activation in vitroNamrata G Jain, Elisabeth A Wong, Alexander J Aranyosi, et al.
Transplantation|February 13, 2015
Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft RejectionKevin P Daly, Jason L J Dearling, Tatsuichiro Seto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 21, 2016
Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipientsKevin P Daly, Maria Stack, Michele F Eisenga, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Cancer Research|November 12, 2009
Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cellsDipak Datta, Alan G Contreras, Aninda Basu, et al.
Current Opinion in Organ Transplantation|November 30, 2016
The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/toleranceJohannes Wedel, Hironao Nakayama, Nora M Kochupurakkal, et al.
Pediatric Nephrology (Berlin, Germany)|April 24, 2015
Translational implications of endothelial cell dysfunction in association with chronic allograft rejectionSarah Bruneau, Johannes Wedel, Fadi Fakhouri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma productionAninda Basu, Andre Hoerning, Dipak Datta, et al.
Biochemical and Biophysical Research Communications|September 23, 2019
Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activationCraig B Woda, Sarah Bruneau, Anne Linde Mak, et al.
Carcinogenesis|December 29, 2021
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantationAkash Sabarwal, Johannes Wedel, Kaifeng Liu, et al.
The American Journal of Pathology|January 27, 2006
Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injurySei-ichiro Tsuchihashi, Bibo Ke, Fady Kaldas, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 2, 2015
Microfluidic mazes to characterize T-cell exploration patterns following activation in vitroNamrata G Jain, Elisabeth A Wong, Alexander J Aranyosi, et al.
Transplantation|February 13, 2015
Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft RejectionKevin P Daly, Jason L J Dearling, Tatsuichiro Seto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 21, 2016
Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipientsKevin P Daly, Maria Stack, Michele F Eisenga, et al.
Pageof 7